Enzyme Engineering stands at the forefront of biotechnology, offering a powerful toolkit for tailoring enzymatic properties to meet diverse industrial and biomedical needs. This discipline encompasses the design, modification, and optimization of enzymes through genetic, protein engineering, and directed evolution approaches. By manipulating enzyme structure and function, scientists can enhance catalytic efficiency, substrate specificity, stability, and tolerance to extreme conditions. Enzyme engineering holds immense promise across a spectrum of applications, including biocatalysis, biotransformation, biofuel production, pharmaceutical synthesis, and environmental remediation. Through rational design or directed evolution strategies, enzymes can be customized to perform specific tasks with unprecedented precision and efficacy. Moreover, enzyme engineering enables the creation of novel biocatalysts capable of catalyzing reactions that are otherwise inaccessible or inefficient with naturally occurring enzymes. This technology has revolutionized industries by enabling cleaner and more sustainable manufacturing processes, reducing energy consumption and waste generation. In the pharmaceutical sector, engineered enzymes play a crucial role in drug discovery, development, and production, accelerating the synthesis of complex molecules and improving therapeutic outcomes. Additionally, enzyme engineering holds promise for personalized medicine, where tailored enzymes could target specific disease pathways with enhanced efficacy and minimal side effects.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain